AzTrials
AzTrials

Radius Fracture DistalLADON radiusNCT05631314

Lets Agree to Disagree on Operative vs Nonoperative Treatment for Distal Radius Fractures in the Elderly (LADON Radius)

An observational study of Radius Fracture Distal, run by Luzerner Kantonsspital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary objective of this study is to determine if non-operative treatment of distal radius fractures in patients aged 65 and over leads to equal funtional results as operative treatment. To do so patients will be included from two "schools" in which treatment i seither predominantly operative or non-operative. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Radius Fracture Distal
What is being tested?
operative treatment and non-operative treatment
Type of treatment
Surgery or procedure
How many people
110 participants
Where
No sites listed yet
Study dates
Feb 2023to Feb 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients presenting to the emergency department or out-patient clinic in one of the participating hospitals.

Who may be able to join

  • ≥ 65 years old
  • acute (< 14 days after injury) distal radius fracture
  • treated at one of the participating hospitals

Who cannot join

  • initial operative treatment at a non-participating hospital
  • delayed presentation (>14 days after injury)
  • patient actively refuses the recommended treatment
  • insufficient follow-up (<12 months) or unavailable to follow-up due to residency in other hospital area
  • concomitant injury to the ipsilateral or contralateral upper extremity
  • cognitive impairment precluding answering questionnaires
Show all 11Show fewer
  • non-German, non-English, non-Dutch speaking
  • pre-existing co-morbidities which preclude operative treatment
  • pathological fractures
  • open fractures
  • neurovascular injury requiring operative treatment

Trial locations and contacts

No sites are listed yet.

Nicole M van Veelen, MD contact

041412051959

nicole.vanveelen@luks.ch

Frank JP Beeres, PD PhD contact

+41412051914

frank.beeres@luks.ch

About this study

Official title: Lets Agree to Disagree on Operative Versus Nonoperative (LADON) Treatment for Distal Radius Fractures in the Elderly - a Prospective International Multicenter Cohort Study

The primary objective of this study is to determine if non-operative treatment of distal radius fractures in patients aged 65 and over leads to equal funtional results as operative treatment. To do so patients will be included from two "schools" in which treatment i seither predominantly operative or non-operative. There will be no study intervention as patients will be treated as per local standard of care. The study is set up as an international multicenter study. Those patients included in the study will be follow-up at 6 weeks, 12 weeks, 1 year and 2 years after treatment was initiated. Our hypothesis is, that patients treated operatively will have better function than those treated non-operatively.

Read the detailed description

This study is an international multicenter prospective observational cohort study for which patients will be identified after treatment has been initiated. Outcome data will be prospectively collected. Patients will be recruited from five hospitals in countries with a predominant preference for operative (Switzerland, "School" A) and non-operative treatment (the Netherlands, "School" B). After a treatment plan has been established, patients will be approached either during the index hospital admission or during one of their follow-up appointments in the outpatient clinic within six weeks to explain the purpose and procedures of the study. Patients will be asked to provide written informed consent. Following the identification of eligible patients, anonymous radiographs including key images of CT-scans if available and baseline characteristics (such as age, co-morbidities, activity level) as well as relevant laboratory results will be made available to the expert panel (details below) on a secure online platform. This will allow the members of the panel to reach a "clinical" decision regarding their treatment recommendation. The panel will be blinded to the actual treatment received and the origin of the case.

The expert panel will consist of three representatives from both "Schools". All panel members will be certified trauma surgeons from one of the participating hospitals. Eligible patients will be reviewed by the experts every two weeks. Patients will ultimately be included in the study if clinical equipoise is achieved, meaning the majority of experts in one "School", minimally two out of three, disagree with the received treatment in the other "School". For example, eligible patients would have received operative treatment based on the expert opinions in "School" A, however, were in fact treated non-operatively according to the treating surgeon in "School" B and vice versa. If the majority of the panel in one "School" agree with the received treatment in the other "School" the patient will be excluded. This will lead to two comparable groups for which true clinical equipoise exists. The actual treatment the patient receives, will continue as initially planned by the treating hospital.

Being tested
operative treatment, non-operative treatment
Keywords
distal radius fracture, elderly, operative treatment, natural experiment
Medical subject headings
Wrist Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • operative treatmentProcedure or surgery

    Operative treatment can consist of open reduction and volar and/or dorsal plating or closed reduction and fixation with K-wires, external fixateur.

  • non-operative treatmentProcedure or surgery

    Non-operative treatment will consist of immobilization in a below the elbow cast for 4-6 weeks with or without prior closed reduction.

Study groups in NCT05631314
Study groupRoleWhat they receive
operative treatmentThis group will consist of patients who underwent operative treatment for a distal radius fracture.
Receives: Procedure: operative treatment
non-operative treatmentThis group will consist of patients who underwent non-operative treatment for a distal radius fracture.
Receives: Procedure: non-operative treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PRWE 12 weeks

    Patient-rated Wrist Evaluation scores measured a t 12 weeks after treatment initiation

    Measured: 12 weeks

Secondary outcomes (8)
  1. PRWE 1 and 2 years

    Patient-rated Wrist Evaluation scores measured 1 and 2 years after treatment initiation

    Measured: 1 year, 2 years

  2. PASE

    Physical activity score of the elderly

    Measured: 12 weeks, 1 year, 2 years

  3. Pain intensity

    numeric rating system for pain

    Measured: 6 weeks, 12 weeks, 1 year, 2 years

  4. range of motion

    range of motion of the wrist

    Measured: 12 weeks, 1 year, 2 years

  5. EQ-5D-5L

    Quality of life score

    Measured: 12 weeks, 1 year, 2 years

  6. Complications

    Complications will be assessed. They will include infection, non-union, implant failure, complex regional pain syndrome and any adverse event need surgical intervention. For patients treated surgically, the need for implant removal will also be recorded.

    Measured: 6 weeks, 12 weeks, 1 year, 2 years

  7. living situation

    the living situation of the patient will be assessed and classified as one of the following categories: independent, independent with support from family/district nurse or similar, nursing home.

    Measured: 6 weeks, 12 weeks, 1 year, 2 years

  8. radiological outcome

    The xrays will be assessed to judge the radiological outcome with regards to loss of reduction.

    Measured: 6 weeks, 12 weeks, 1 year, 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Nov 2022
  2. Study startFeb 2023 (estimated)
  3. Primary completionMay 2024 (estimated)
  4. Study completionFeb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05631314
Sponsor's protocol ID
LADON radius
Acronym
LADON radius
Status last verified
Nov 2022
First submitted
21 Nov 2022
Last updated
30 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Radius Fracture Distal, run by Luzerner Kantonsspital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nicole M van Veelen, MD (041412051959, nicole.vanveelen@luks.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PRWE 12 weeks (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2022; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in